Summary: Clinical features of hepatocellular carcinoma in 22 patients without serum HBsAg, HBV DNA, anti-HCV antibody and HCV RNA were characterized and possible pathogenic factors for this cryptogenic hepatocellular carcinoma were prospectively assessed. Twenty-two patients were selected from 434 patients with hepatocellular carcinoma (HCC) who were treated at the Second
INTRODUCTION
The incidence of hepatocellular carcinoma (HCC) in Japan is higher than in western countries [1] . Persistent infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) is considered as the causative pathogenic factor in 95% of HCC [2, 3] . However, 5% of patients with HCC are negative for chronic infection of HBV or HCV and the clinical characteristics and suspected pathogenic factors in these have not been elucidated.
Although aflatoxines was reported [4] [5] [6] as a pathogenic factor other than hepatitis virus, its incidence in Japan was considered low. PCR technique has made it possible to detect HBV or HCV infection in a few HCC patients in whom the virus has been previously undetectable. Recently, a new hepatitis virus designated GB virus C/hepatitis G virus (GBV-C/HGV) was isolated [7] [8] [9] but it has less importance as a possible causative virus of non B non C HCC. was considered to have a low antibody titer. The region of the S gene of HBV encoding HBsAg was amplified by PCR using primers complementary to the 32nd-52nd and to the 272nd-292nd nucleotides. Anti-HCV was detected by second generation assays (passive hemagglutination assay and/or enzyme immunoassay, Dainabbott Co., Ltd., Tokyo, Japan). HCV RNA was detected by reverse transcriptase " nested " polymerase chain reaction (RT-PCR) using primers derived from the highly conserved 5' -UTR region as described previously [11] .
The presence of GBV-C/HGV RNA was detected by RT-hemi-nested PCR. PCR was performed using hemi-nested primers specific for the highly conserved region (5'-UTR) of the GBV-C/HGV gnome as described by Wu et al. [12] .
Detection of auto antibodies in serum samples ANA, ASMA, and AMA were detected by indirect immunofluorescence test. To detect ANA, serum samples were first mixed with Hep2 cells established from human pharyngeal carcinoma, and then subjected to indirect immunofluorescence test with anti-human immunoglobulins IgA, M, and G that were labeled with FITC (fluorescein isothiocyanate) (FLUORO HEPANA TEST' , MBL Co., Ltd., Nagoya, Japan). The reaction was defined as positive when either diffuse or granular signals were clearly detected in nuclei. In case of positive results, antibody titration was carried out using samples prepared in a series of repeated two-fold dilutions. To detect ASMA and ANA, drops of serum samples were placed onto sections of stomach (smooth muscle) and kidney specimens from rats fixed on slide glass, respectively. After incubation, antibodies were detected by indirect immunofluorescence test with anti-human IgA, M and G that had been prelabeled with FITC (FLURO AID-1 TEST', MB L Co., Ltd.). When positive signals were detected in the muscular layer of the mucosa, smooth muscles in the muscular layer, submucosal tissue, and vascular wall in the stomach specimen, the serum sample was defined as positive for ASMA. When positive signals were detected in the cytoplasm of distal or proximal renal epidermal cells and in epidermal cells in the gastric wall, the sample was defined as AMA positive. When ASMA and/or AMA were positive, the antibody titration was carried out using samples prepared in a series of repeated two-fold dilutions.
Statistical analysis
Statistical analysis was performed by student's ttest. For correlation analysis, Spearman's rank correlation was used. A probability of less than 0.05 was considered significant. fibrosis, but neither inflammatory cells infiltrating into the portal areas nor alcoholic liver disease were observed (Fig. 2) . In the remaining patient (No. 1), histological findings of resected specimen revealed normal liver (Fig. 3 ).
In the other 19 patients, 13 had clinically diagnosed as liver cirrhosis and 6 as chronic hepatitis (Table 2) .
Symptoms prior to the detection of non-B non-C HCC and tumor stage at diagnosis Seven patients were underwent regular check-up (periodic check-up group) and remaining 15 were not underwent regular check-up (non-periodic check-up group). In 6 patients with liver cirrhosis, HCC was [2] , consisting to the findings in the present study. Characterization of clinical features specific to this cryptogenic HCC and the search for candidate causative factors involved in development HCC is obviously important to add a new category of patients at high-risk of developing non-B non-C HCC. These findings are also crucial to understanding the underlying mechanism of carcinogenesis in cryptogenic HCC. Among 22 patients with HCC evaluated in the present study, as many as 16 had a history of alcoholic liver disease. Five had schistosomiasis Japonica or Budd-Chiari syndrome as an accompanying disease. Although ethanol is a potential carcinogenic promoter [13] , the incidence of HCC in which heavy habitual consumption of alcohol alone may have caused the liver disease is low in Japanese [14] . However, it should be emphasized that habitual consumption of alcohol is a well known risk factor for liver cirrhosis [15, 16] , and HCC often develops in patients with liver cirrhosis. Therefore, alcoholic liver disease by itself could be a carcinogenic condition promoting HCC. Eight of 16 patients (50%) with alcoholic liver disease were positive for anti-HBc antibody though negative for HBV DNA. This positivity rate for antiHBc antibody was not very high compared with that generally seen in the local population [17] . However, more sensitive methods of detecting HBV DNA in serum and liver tissue may demonstrate a higher HBV positivity rate and provide a clue for a possible relationship between HBV and pathogenesis of this cryptogenic HCC.
GBV-C/HGV RNA was detected only in 1 of the 22 patients. This low incidence is consistent with the reported by Sugai et al. [18] that GBV-C/HGV RNA was detected only in 1 of 12 patients with non-B non-C chronic liver disease. Kao et al. [19] also reported co-infection with GBV-C/HGV in patients who were positive for hepatitis B or hepatitis C did not cause any alteration in clinical features during follow-up with respect to development of HCC. Taken together with the present findings, involvement of GBV-C/HGV in the pathogenesis of non-B non-C HCC may be unlikely.
The high incidence of schistosomiasis Japonica in the present cases (6/22) is likely due to the fact this disease was previously endemic in this area [20] . In our previous study, HBV or HCV infection was detected in serum samples from all 25 patients with schistosomiasis Japonica who developed HCC [21] . These results strongly suggest that infection with HBV or HCV plays an important role in the pathogenesis of HCC in patients regardless of a history of schistosomiasis Japonica.
Several reports suggest that patients with BuddChiari syndrome are predisposed to HCC [22] [23] [24] . The only one patient with Budd-Chiari syndrome in the present case (Pt No. 14) was negative for all known hepatitis viral markers and did not show any particular histological anomaly in the non-cancerous portion of the liver beyond the ordinary chronic passive congestive fibrosis seen in alcoholic liver disease. In this patient, therefore, chronic congestion in the liver may have caused HCC.
Rayder et al. [4] reported that HCV infection was often detected in patients with autoimmune hepatitis (AIH) who developed HCC. Komada et al. [5] reported that a patient with primary biliary cirrhosis (PBC) accompanied by HCC was negative for all HBV related markers, anti-HCV antibody, and HCV RN A in serum. In our patient 11 (Table 2) , autoimmune hepatitis was also implicated by the finding of inflammatory cells, primarily lymphocytes and plasmacytes, had infiltrated the portal areas. These results suggest that there may be a causal relationship between autoimmune hepatitis and the development of HCC, although the incidence is low. This issue deserves further investigation. Regarding the incidence of patients positive for autoantibody in this study, the positivity rate for ANA and ASMA was as high as 30.8% (7/22) and 77.3% (17/22) , respectively. The positivity rate in patients with HCC has been reported to be significantly higher than that in patients with chronic hepatitis, those with liver cirrhosis, or with tumor in organs other than the liver [25] . There is also a reportconversion from negative to positive ANA with an antibody titer in increments [26] . Thus, the high incidence of ANA positivity among HCC patients may reflect malignant transformation of hepatocytes. The high incidence of ANA positivity in the present cases may be explained by this carcinogenic event.
Among 7 patients who periodically underwent a complete medical examination for alcoholic liver disease or cryptogenic liver disorders that are prone to development of HCC, HCC was detected in 6 patients in its earlier stage (stage I or II). The tumor stage when HCC was detected among patients in the periodic follow-up group was earlier than that detected among those who did not undergo the periodic follow-up.
The clinical aspects of the non-B non-C cryptogenic HCC studied here suggest that patients with alcoholic liver disease, autoimmune hepatitis, or auto antibody should also undergo follow-ups for HCC. The present findings warrant further research to identify other viruses that are carcinogenic to the liver.
